Kromek Group (LON:KMK) Stock Falls 2.4% – Time to Sell?

Shares of Kromek Group plc (LON:KMK) dropped 2.4% on Monday. The company traded as low as GBX 5.30 and last traded at GBX 5.31. Approximately 1,771,036 shares were traded during mid-day trading, a decline of 6% from the average daily volume of 1,889,199 shares. The stock had previously closed at GBX 5.44.

Kromek Group Stock Performance

The stock has a market capitalization of £34.78 million, a PE ratio of 53.07 and a beta of 1.34. The company has a quick ratio of 0.82, a current ratio of 2.39 and a debt-to-equity ratio of 17.19. The firm has a 50 day moving average price of GBX 6.22 and a 200-day moving average price of GBX 8.77.

Kromek Group (LON:KMK) last released its earnings results on Monday, September 14th. The company reported GBX 0.40 EPS for the quarter. Kromek Group had a return on equity of 1.32% and a net margin of 2.70%.

Insider Transactions at Kromek Group

In other Kromek Group news, insider Rakesh Sharma acquired 145,454 shares of the firm’s stock in a transaction on Tuesday, September 15th. The stock was acquired at an average cost of GBX 7 per share, for a total transaction of £10,181.78. Corporate insiders own 8.34% of the company’s stock.

Kromek Group Company Profile

Our goal is a simple one, to make the world a safer and healthier place; we’re striving to support the global effort in Radiological and Biological Threat detection and management, as well enhance the quality of Advanced Imaging for the medical and industrial sectors, through our evolved, innovative and field proven products and solutions.
Kromek Group designs, develops, manufactures and markets both hardware and software of CZT solid-state Radiation Detectors and Scintillation Radiation Detector components and products to OEM, Civil Nuclear, Security Sectors and Government Bodies across the globe.